The primary objectives of this non-interventional register study are to estimate the country specific incidence of CLL/SLL between 2014–2024 and to describe the demographic and clinical characteristics of CLL patients residing in the Nordics (Denmark (DK); Finland (FI); Norway (NO)). The secondary objectives are to characterize CLL/SLL treatment patterns, clinical outcomes, and HCRU and related costs among patients with CLL/SLL in DK, FI, and NO separately.
